Quarterly report pursuant to sections 13 or 15(d)

GENERAL

v2.3.0.11
GENERAL
6 Months Ended
Jun. 30, 2012
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GENERAL

 

Amarantus BioSciences, Inc. (the “Company”) was incorporated on January 14, 2008 in the state of Delaware. The Company is a development stage biopharmaceutical drug development company dedicated to discovering and sourcing high-potential bioscience platform technologies and developing them towards commercialization. Through June 30, 2012, the Company has been primarily engaged in biotechnology research and development and raising capital.